When I discuss Healing the Sick Care System: Why People Matter with audiences, I expect nods of recognition acknowledging the…
Every January, San Francisco undergoes a transformation. For one week, the city shifts into high gear for the life sciences…
Although rare by definition, the collective impact of rare diseases is anything but insignificant. In the Asia-Pacific (APAC) region – home…
Craig Martin is a strategic chameleon in health innovation. He is equally at home in boardrooms, nonprofit leadership, consulting and…
I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked…
Patient Experience is the Key to Improving Drug Development and Health Care, but Are We Listening?
When the health ecosystem discounts patient experience, it fails individuals and incurs added costs. Delayed diagnoses lead to prolonged suffering,…
EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger
Covid is commonplace. Some, are laid up with symptoms for days or weeks. A smaller group risks hospitalization or death.…
“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More